Literature DB >> 34299213

The MEK5/ERK5 Pathway in Health and Disease.

Rupesh Paudel1, Lorenza Fusi1, Marc Schmidt1.   

Abstract

The MEK5/ERK5 mitogen-activated protein kinases (MAPK) cascade is a unique signaling module activated by both mitogens and stress stimuli, including cytokines, fluid shear stress, high osmolarity, and oxidative stress. Physiologically, it is mainly known as a mechanoreceptive pathway in the endothelium, where it transduces the various vasoprotective effects of laminar blood flow. However, it also maintains integrity in other tissues exposed to mechanical stress, including bone, cartilage, and muscle, where it exerts a key function as a survival and differentiation pathway. Beyond its diverse physiological roles, the MEK5/ERK5 pathway has also been implicated in various diseases, including cancer, where it has recently emerged as a major escape route, sustaining tumor cell survival and proliferation under drug stress. In addition, MEK5/ERK5 dysfunction may foster cardiovascular diseases such as atherosclerosis. Here, we highlight the importance of the MEK5/ERK5 pathway in health and disease, focusing on its role as a protective cascade in mechanical stress-exposed healthy tissues and its function as a therapy resistance pathway in cancers. We discuss the perspective of targeting this cascade for cancer treatment and weigh its chances and potential risks when considering its emerging role as a protective stress response pathway.

Entities:  

Keywords:  Krüppel-like factor; atherosclerosis; bone; cartilage; endothelium; extracellular-regulated kinase 5; mechanotransduction; mitogen-activated protein kinase; stress signaling; tumor

Year:  2021        PMID: 34299213     DOI: 10.3390/ijms22147594

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  5 in total

Review 1.  Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy.

Authors:  Xiaoli Pan; Junping Pei; Aoxue Wang; Wen Shuai; Lu Feng; Faqian Bu; Yumeng Zhu; Lan Zhang; Guan Wang; Liang Ouyang
Journal:  Acta Pharm Sin B       Date:  2022-01-04       Impact factor: 14.903

2.  Fine Mapping of the MAP2K5 Region Identified rs7175517 as a Causal Variant Related to BMI in China and the United Kingdom Populations.

Authors:  Ce Lu; Hai-Jun Wang; Jie-Yun Song; Shuo Wang; Xue-Ying Li; Tao Huang; Hui Wang
Journal:  Front Genet       Date:  2022-03-16       Impact factor: 4.599

Review 3.  Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.

Authors:  Matilde Monti; Jacopo Celli; Francesco Missale; Francesca Cersosimo; Mariapia Russo; Elisa Belloni; Anna Di Matteo; Silvia Lonardi; William Vermi; Claudia Ghigna; Emanuele Giurisato
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

Review 4.  Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician.

Authors:  Salvatore De Rosa; Claudio Iaconetti; Ceren Eyileten; Masakazu Yasuda; Michele Albanese; Alberto Polimeni; Jolanda Sabatino; Sabato Sorrentino; Marek Postula; Ciro Indolfi
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

Review 5.  Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.

Authors:  Katie Joanna Miller; Mohammad Asim
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.